Merck & Co., Inc. Retained Earnings 2008-2026 | MRK
Beta
What is retained earnings?
Retained earnings represent the cumulative net income that has been reinvested in the business rather than distributed as dividends to shareholders.
What is Merck & Co., Inc.'s current retained earnings?
Merck & Co., Inc. (MRK) annual retained earnings for 2025 was $73.08B, a 15.87% increase from 2024. Merck & Co., Inc. retained earnings for the quarter ending March 31, 2026 was $66.72B.
What was Merck & Co., Inc.'s retained earnings in 2024?
Merck & Co., Inc. annual retained earnings for 2024 was $63.07B, a 17.02% increase from 2023.
What was Merck & Co., Inc.'s retained earnings in 2023?
Merck & Co., Inc. annual retained earnings for 2023 was $53.90B, a 11.76% decline from 2022.
What is Merck & Co., Inc.'s 5-year retained earnings CAGR?
Merck & Co., Inc. retained earnings grew at a compound annual growth rate (CAGR) of 9.06% from FY2020 to FY2025, going from $47.36B to $73.08B over 5 years.
Retained Earnings History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGR+9.1%
FY2020
$47.36B
→
FY2025
$73.08B
080910111213141516171819202122232425
5 years selected
Retained Earnings History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $73.08B | +15.9% | 10-K |
| FY2024 | $63.07B | +17.0% | 10-K |
| FY2023 | $53.90B | -11.8% | 10-K |
| FY2022 | $61.08B | +13.8% | 10-K |
| FY2021 | $53.70B | +13.4% | 10-K |
| FY2020 | $47.36B | +1.6% | 10-K |
| FY2019 | $46.60B | +9.4% | 10-K |
| FY2018 | $42.58B | +3.0% | 10-K |
| FY2017 | $41.35B | -6.3% | 10-K |
| FY2016 | $44.13B | -2.7% | 10-K |
| FY2015 | $45.35B | -1.5% | 10-K |
| FY2014 | $46.02B | +17.2% | 10-K |
| FY2013 | $39.26B | -1.8% | 10-K |
| FY2012 | $39.98B | +2.6% | 10-K |
| FY2011 | $38.99B | +3.9% | 10-K |
| FY2010 | $37.54B | -9.3% | 10-K |
| FY2009 | $41.41B | -5.2% | 10-K |
| FY2008 | $43.70B | - | 10-K |
Company: Merck & Co., Inc.Ticker: MRKSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →